Everyone Healthy Library
Hepatocellular Carcinoma
Condition / disease reference page from the Everyone Healthy database.
! Seek urgent medical care if warning signs appear
Some health conditions or symptoms can become urgent. Use this page for education, but seek help quickly if warning signs are present.
Get urgent medical care now if there is any severe, sudden, rapidly worsening or worrying symptom, especially:
- chest pain, pressure or pain spreading to the arm, jaw or back
- trouble breathing, blue lips, severe wheeze or choking
- stroke-like symptoms such as face drooping, arm weakness or speech trouble
- collapse, fainting, seizure, confusion or extreme drowsiness
- severe bleeding, black stools, vomiting blood or major injury
- severe allergic reaction, swelling of the face/throat or widespread rash with breathing trouble
- severe abdominal pain, severe headache, stiff neck or sudden vision change
- signs of severe dehydration, sepsis, high fever with worsening illness, or symptoms in a baby/young child that concern you
Connected health information
Explore this condition in a clear order
Condition overview
Attributes
Linked signs and symptoms
7Each sign/symptom opens its own page and links back to related conditions.
Linked drugs / medications
1Medication information is educational only. A doctor or pharmacist should advise whether any medicine is appropriate.
Treatments, therapies and supportive options
17Grouped by treatment type. These are educational database links, not personal treatment recommendations. Evidence labels are shown only where stored in the EH database.
Surgery
3Medical therapy
8- ChemotherapyWeakly in Favour(Low Evidence)
- Hepatic Arterial ChemoembolizationWeakly in Favour(Low Evidence)
- Hepatic ResectionWeakly in Favour(Low Evidence)
- Intratumoral Ethanol InjectionWeakly in Favour(Low Evidence)
- Liver TransplantWeakly in Favour(Low Evidence)
- Liver TransplantationWeakly in Favour(Low Evidence)
- Radiation TreatmentWeakly in Favour(Low Evidence)
- Radiofrequency CoagulationWeakly in Favour(Low Evidence)
Linked diagnostic tests and investigations
34These are pulled from both EH diagnostic-test link tables, including the older large test-link table.
- Acid Phosphatase Concentration
- Activated Coagulation Time (ACT)
- Activated Partial Thromboplastin Time (APTT)
- Alpha-1 Antitrypsin (AAT) Concentration
- Alpha-Fetoprotein (AFP, Serum AFP, Blood)
- Ammonia Concentration Test
- Apolipoprotein A Concentration
- Apolipoprotein B Concentration
- Aspartate Aminotransferase (AST) Concentration
- Blood Uric Acid Concentration Test
- Cholinesterase (Serum Acetylcholinesterase, Pseudocholinesterase)
- Coagulation Factor Assay (Blood Clotting Factors)
- Creatine Kinase Concentration
- D-Dimer Blood Test
- Fecal Urobilinogen Concentration
- Fibrin Degradation Products (FDPs, Fibrin Split Products, FSPs, Fibrin Breakdown Products, Fbps)
- Fibrin Monomers Test
- Fibrinogen Concentration test
- Fibrinopeptide A (FPA) Action Assay
- Gamma-Glutamyltransferase (GGT) Concentration
- haptoglobin (Hp) concentration
- High Density Lipoprotein (HDL) Concentration
- Lactate Dehydrogenase Concentration
- lipase concentration
- Low Density Lipoprotein (LDL) Concentration
- Mean Corpuscular Volume (MCV)
- Phenylketonuria Test
- Plasminogen Activity
- Potassium Concentration (K, Blood)
- Protein Electrophoresis (Blood, Serum Protein)
- Prothrombin Time (PT)
- Thyroglobulin (Tg) Concentration
- Urine Sodium Quantitative (24hr)
- Vitamin B12 (VB12) Concentration
Biological markers/agents
39This visual map shows biological markers/agents reported as increased or decreased with this condition. These are educational relationships only; test results must be interpreted by a qualified clinician because ranges vary by lab, method, age, sex and clinical context.
Often increased
24- Acid PhosphataseReference range exampleChild (0 - 16y), Male: 8.7–12.5 units/L; Adult ( > 16y), Male: 2.2–10.4 units/LLinked diagnostic testsAcid Phosphatase Concentration
- Alpha-1 Antintrypsin (AAT)Reference range exampleAdult ( > 16y): 90–215 mg/dLLinked diagnostic testsAlpha-1 Antitrypsin (AAT) Concentration
- Alpha-1-Globulin (Blood, Serum)Reference range exampleAll: 0.1–0.3 gm/dLLinked diagnostic testsProtein Electrophoresis (Blood, Serum Protein)
- Alpha-2-Globulin (Blood, Serum)Reference range exampleAll: 0.6–1 gm/dLLinked diagnostic testsProtein Electrophoresis (Blood, Serum Protein)
- Alpha-Fetoprotein (Non-Pregnant, Serum)Reference range exampleAll: 5–40 ng/mLLinked diagnostic testsAlpha-Fetoprotein (AFP, Serum AFP
- AmmoniaReference range exampleAdult ( > 16y): 6–48 µmol/LLinked diagnostic testsAmmonia Concentration Test
- Apolipoprotein B (Apo B)Reference range exampleAdult ( > 16y), Female: 47–115 mg/dL; Adult ( > 16y), Male: 52–120 mg/dLLinked diagnostic testsApolipoprotein B Concentration
- Aspartate Aminotransferase (AST)Reference range exampleAdult ( > 16y), Female: 10–25 units/L; Adult ( > 16y), Male: 10–35 units/LLinked diagnostic testsAspartate Aminotransferase (AST) Concentration
- Coagulation Bleeding TimeReference range exampleAdult ( > 16y): 65–110 secondsLinked diagnostic testsActivated Coagulation Time (ACT)
- D-DimerReference range exampleAdult ( > 16y): 0–240 µg/LLinked diagnostic testsD-Dimer Blood Test
- Fibrin MonomersReference range example0–10,000 µg/LLinked diagnostic testsFibrin Monomers Test
- Fibrin Split ProductsReference range exampleAll: 0–1 mg/dLLinked diagnostic testsFibrin Degradation Products (FDPs, Fibrin Split Products
- Fibrinopeptide A (FPA)Reference range exampleAdult ( > 16y), Female: 0.7–3.1 mg/mL; Adult ( > 16y), Male: 0.35–2.5 mg/mLLinked diagnostic testsFibrinopeptide A (FPA) Action Assay
- Gamma Globulin (Blood, Serum)Reference range exampleAll: 0.8–1.7 gm/dLLinked diagnostic testsProtein Electrophoresis (Blood, Serum Protein)
- Gamma-Glutamyltransferase (GGT)Reference range exampleAdult ( > 16y), Female: 6–30 units/L; Adult ( > 16y), Male: 6–38 units/LLinked diagnostic testsGamma-Glutamyltransferase (GGT) Concentration
- haptoglobin (Hp)Reference range example45–200 mg/dLLinked diagnostic testshaptoglobin (Hp) concentration
- Lactate Dehydrogenase (LDH)Reference range exampleInfant (0 - 1y): 120–250 units/L; Adult ( > 16y): 100–200 units/LLinked diagnostic testsLactate Dehydrogenase Concentration
- LipaseReference range exampleAdult ( > 16y): 10–140 units/LLinked diagnostic testslipase concentration
- Low Density Lipoprotein (LDL)Reference range exampleAdult ( > 16y): 0–125 mg/dL; 6y - 16y: 0–100 mg/dLLinked diagnostic testsLow Density Lipoprotein (LDL) Concentration
- PhenylalanineReference range exampleAdult ( > 16y): 0–16 mg/24hrs; Child (5 - 12y): 4–16.5 mg/24hrsLinked diagnostic testsPhenylketonuria Test
- Plasma thromboplastin antecedentReference range exampleAdult ( > 16y): 20–35 secondsLinked diagnostic testsActivated Partial Thromboplastin Time (APTT)
- Prothrombin TimeReference range exampleAdult ( > 16y): 10–13 secondsLinked diagnostic testsProthrombin Time (PT)
- Thyroglobulin (Tg)Reference range exampleInfant (0 - 1y), Female: 0.4–5.6 ng/mL; Infant (0 - 1y), Male: 0.5–5.6 ng/mLLinked diagnostic testsThyroglobulin (Tg) Concentration
- Vitamin B12 (VB12)Reference range exampleAdult ( > 16y): 130–670 pmol/LLinked diagnostic testsVitamin B12 (VB12) Concentration
Often decreased
15- Albumin (Blood)Reference range exampleAdult ( > 16y): 37–52 gm/dL; Infant (0 - 1y): 4.4–5.4 gm/dLLinked diagnostic testsBlood Albumin Concentration, Protein Electrophoresis (Blood
- Apolipoprotein A (Apo A)Reference range exampleAdult ( > 16y), Female: 85–170 mg/dL; Adult ( > 16y), Male: 77–155 mg/dLLinked diagnostic testsApolipoprotein A Concentration
- CholinesteraseReference range exampleAll: 6–19 U/mLLinked diagnostic testsCholinesterase (Serum Acetylcholinesterase, Pseudocholinesterase)
- Creatine Kinase (CK)Reference range exampleAdult ( > 16y), Female: 35–150 units/L; Adult ( > 16y), Male: 40–170 units/LLinked diagnostic testsCreatine Kinase Concentration
- Factor IX (Christmas Factor, Percentage of Normal Value)Reference range exampleAdult ( > 16y): 60–140 %Linked diagnostic testsCoagulation Factor Assay (Blood Clotting Factors)
- Factor V (Labile Factor, Proaccelerin, Percentage of Normal Value)Reference range exampleAdult ( > 16y): 50–150 %Linked diagnostic testsCoagulation Factor Assay (Blood Clotting Factors)
- Factor X (Stuart Prower Factor, Percentage of Normal Value)Reference range exampleAdult ( > 16y): 45–155 %Linked diagnostic testsCoagulation Factor Assay (Blood Clotting Factors)
- FibrinogenReference range exampleAdult ( > 16y): 150–400 mg/dLLinked diagnostic testsFibrinogen Concentration test
- High Density Lipoprotein (HDL)Reference range exampleAdult ( > 16y), Female: 53–500 mg/dL; Adult ( > 16y), Male: 45–500 mg/dLLinked diagnostic testsHigh Density Lipoprotein (HDL) Concentration
- PlasminogenReference range exampleAdult ( > 16y), Female: 65–153 %; Adult ( > 16y), Male: 70–120 %Linked diagnostic testsPlasminogen Activity
- Potassium (K, Blood)AbbreviationKReference range exampleInfant (0 - 1y): 4.1–5.3 mEq/L; Child (0 - 16y): 3.4–4.7 mEq/LLinked diagnostic testsPotassium Concentration (K, Blood)
- Red Blood Cell (RBC) VolumeReference range example76–100 fLLinked diagnostic testsMean Corpuscular Volume (MCV)
- Uric Acid, BloodReference range exampleAdult ( > 16y), Female: 2.5–7 mg/dL; Adult ( > 16y), Male: 4–8 mg/dLLinked diagnostic testsBlood Uric Acid Concentration Test
- Urine SodiumReference range exampleChild (0 - 16y): 41–115 mmol/day; Adult ( > 16y): 40–220 mmol/dayLinked diagnostic testsUrine Sodium Quantitative (24hr)
- Urobilinogen (Stools)Reference range exampleAll: 50–300 mg/24hrsLinked diagnostic testsFecal Urobilinogen Concentration
Introduction / full article
Hepatocellular Carcinoma
Summary References
Treatments:
1. http://www.merck.com/mmpe/sec03/ch029/ch029d.html#sec03-ch029-ch029d-600a
2. Chen, Min-Shan; Li, Jin-Qing; Zheng, Yun; Guo, Rong-Ping; Liang, Hui-Hong; Zhang, Ya-Qi; Lin, Xiao-Jun; Lau, Wan Y (2006). "A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma". Annals of Surgery 243 (3): 321–8.
3. American Society of Clinical Oncology, 2005 Annual Meeting, Abstracts on Hepatobiliary Cancer